Interestingly, the TriKE CD16 × CD33 × IL-15, in which one of the antibodies has been substituted with an immunostimulating cytokine such as IL-15, has been also reported to stimulate NK-cell function to overcome immune suppression mediated by MDSCs in MDS [239]. The gene discussed is FCGR3A; the disease is myelodysplastic syndrome.